الصفحة الرئيسية>>Signaling Pathways>> Others>>(R)-Oxiracetam

(R)-Oxiracetam

رقم الكتالوجGC34991

(R) -Oxiracetam هو (R) -enantiomer لعقار أوكسيراسيتام منشط الذهنOxiracetam (ISF 2522) هو دواء منشط الذهن من عائلة racetam ومنبه

Products are for research use only. Not for human use. We do not sell to patients.

(R)-Oxiracetam التركيب الكيميائي

Cas No.: 68252-28-8

الحجم السعر المخزون الكميّة
5mg
130٫00
متوفر
10mM (in 1mL Water)
142٫00
متوفر
50mg
732٫00
متوفر
100mg
1294٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(R)-Oxiracetam is the (R)-enantiomer of the nootropic drug oxiracetam. Oxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.IC50 value:Target: nootropic drugOxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.[1][2] Several animal studies suggest that the substance is safe even when high doses are consumed for a long period of time.[medical citation needed] However, the mechanism of action of the racetam drug family is still a matter of research. Oxiracetam is not approved by Food and Drug Administration for any medical use in the United States.

[1]. Malykh AG, et al. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs. 2010 Feb 12;70(3):287-312. [2]. Valzelli L, et al. Difference in learning and retention by Albino Swiss mice. Part III. Effect of some brain stimulants. Methods Find Exp Clin Pharmacol. 1986 Jun;8(6):337-41.

مراجعات

Review for (R)-Oxiracetam

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (R)-Oxiracetam

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.